These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30714289)

  • 1. Maximum vs minimum harmonization: what to expect from the institutional and legal battles in the EU on gene editing technologies.
    Purnhagen KP; Wesseler JH
    Pest Manag Sci; 2019 Sep; 75(9):2310-2315. PubMed ID: 30714289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editing EU legislation to fit plant genome editing: The use of genome editing technologies in plant breeding requires a novel regulatory approach for new plant varieties that involves farmers.
    Ricroch AE; Ammann K; Kuntz M
    EMBO Rep; 2016 Oct; 17(10):1365-1369. PubMed ID: 27629042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options to Reform the European Union Legislation on GMOs: Scope and Definitions.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 Mar; 38(3):231-234. PubMed ID: 32059122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will the EU stay out of step with science and the rest of the world on plant breeding innovation?
    Jorasch P
    Plant Cell Rep; 2020 Jan; 39(1):163-167. PubMed ID: 31754780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving EU regulatory framework for precision breeding.
    Eriksson D
    Theor Appl Genet; 2019 Mar; 132(3):569-573. PubMed ID: 30328510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise plant breeding using new genome editing techniques: opportunities, safety and regulation in the EU.
    Hartung F; Schiemann J
    Plant J; 2014 Jun; 78(5):742-52. PubMed ID: 24330272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A research program for the socioeconomic impacts of gene editing regulation.
    Whelan AI; Lema MA
    GM Crops Food; 2017 Jan; 8(1):74-83. PubMed ID: 28080208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders.
    Wesseler J; Politiek H; Zilberman D
    Front Plant Sci; 2019; 10():1597. PubMed ID: 31921246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian regulatory aspects of gene editing technologies.
    Ellens KW; Levac D; Pearson C; Savoie A; Strand N; Louter J; Tibelius C
    Transgenic Res; 2019 Aug; 28(Suppl 2):165-168. PubMed ID: 31321700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory hurdles for genome editing: process- vs. product-based approaches in different regulatory contexts.
    Sprink T; Eriksson D; Schiemann J; Hartung F
    Plant Cell Rep; 2016 Jul; 35(7):1493-506. PubMed ID: 27142995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Certain new plant breeding techniques and their marketability in the context of EU GMO legislation - recent developments.
    Zimny T; Sowa S; Tyczewska A; Twardowski T
    N Biotechnol; 2019 Jul; 51():49-56. PubMed ID: 30779963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EU Court of Justice extends the GMO Directive to gene-edited organisms.
    Ruffell D
    FEBS Lett; 2018 Nov; 592(22):3653-3657. PubMed ID: 30426476
    [No Abstract]   [Full Text] [Related]  

  • 13. Canadian regulatory perspectives on genome engineered crops.
    Smyth SJ
    GM Crops Food; 2017 Jan; 8(1):35-43. PubMed ID: 27858499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR plants now subject to tough GM laws in European Union.
    Callaway E
    Nature; 2018 Aug; 560(7716):16. PubMed ID: 30065322
    [No Abstract]   [Full Text] [Related]  

  • 15. Separate product from process: framing the debate that surrounds the potential uptake of new breeding technologies.
    Parry G; Jose S
    Physiol Plant; 2018 Dec; 164(4):372-377. PubMed ID: 29220093
    [No Abstract]   [Full Text] [Related]  

  • 16. The EU regulatory framework on genetically modified organisms (GMOs).
    Bruetschy C
    Transgenic Res; 2019 Aug; 28(Suppl 2):169-174. PubMed ID: 31321701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fruit crops in the era of genome editing: closing the regulatory gap.
    Alvarez D; Cerda-Bennasser P; Stowe E; Ramirez-Torres F; Capell T; Dhingra A; Christou P
    Plant Cell Rep; 2021 Jun; 40(6):915-930. PubMed ID: 33515309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products.
    Menary J; Hobbs M; Mesquita de Albuquerque S; Pacho A; Drake PMW; Prendiville A; Ma JK; Fuller SS
    PLoS One; 2020; 15(3):e0229952. PubMed ID: 32196508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.